RecruitingNCT06178120
Disease Progression in Women With X-linked Adrenoleukodystrophy
An Observational Study to Assess Disease Progression in Women With X-linked Adrenoleukodystrophy
Sponsor
Minoryx Therapeutics, S.L.
Enrollment
40 participants
Start Date
Jan 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Observational, single-site prospective and minimally interventional study in women with X-linked adrenoleukodystrophy (ALD), conducted in France.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with x-linked adrenoleukodystrophy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06178120